The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...
The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...
For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...
Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...
With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...
New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
Opportunities in the Next Generation Cancer Diagnostics Market include leveraging advancements in genomic and proteomic ...
According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results